CW October 2005
Volume 14Issue Number 10 October 2005 ISSN 10593802 Radiopharmaceuticals for Bone CancerRadiopharmaceuticals are agents that carry radionuclide that are targeted to certain cancer cells. For targeting bone cancer cells, samarium-153 is carried via a bone-seeking chemical (EDTMP). A recent study suggests that the inclusion of a radiosensitizer may improve the efficacy of the radionuclide.
Go to Previous Page Go to Next Page Source & Additional Reading P. Anderson, Clinical Cancer Research, October 1, 2005. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW October 2005Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
